Internal Medicine, Gastroenterology · Philadelphia, PA
NPI
1790753317
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
3400 Civic Center Blvd Fl 4
Philadelphia, PA, 19104
Phone (215) 349-8222
Groups this clinician bills Medicare through
Medicare paid, 2024
$56K
815 services
Medicare patients, 2024
331
Average age 69
Drug cost, 2024
$550K
921 prescriptions
Company payments, 2025
$6,229
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kenneth Rothstein was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 265 times for 200 patients. In total Kenneth Rothstein billed 815 services in 18 codes, and Medicare paid $56K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-10-04.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 265 | 200 | $13.32 | $3,531 |
| 99214 Office E&M - Established | Office | 125 | 102 | $101.53 | $13K |
| 99215 Office E&M - Established | Office | 81 | 71 | $142.67 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 65 | 55 | $13.27 | $863 |
| 99232 Hospital E&M - Subsequent | Facility | 45 | 22 | $62.29 | $2,803 |
| 99213 Office E&M - Established | Office | 43 | 38 | $74.15 | $3,189 |
| 99215 Office E&M - Established | Facility | 35 | 30 | $111.21 | $3,892 |
| 99204 Office E&M - New | Office | 29 | 29 | $137.66 | $3,992 |
| 99205 Office E&M - New | Office | 28 | 28 | $160.46 | $4,493 |
| 99214 Office E&M - Established | Facility | 25 | 24 | $78.51 | $1,963 |
| 99222 Hospital E&M - Initial | Facility | 21 | 21 | $104.68 | $2,198 |
| 99213 Office E&M - Established | Facility | 11 | 11 | $53.33 | $587 |
| 99205 Office E&M - New | Facility | 11 | 11 | $146.10 | $1,607 |
By year: 2022 $62K for 567 services; 2023 $52K for 475 services; 2024 $56K for 815 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kenneth Rothstein prescribed most often to Medicare patients was Ursodiol, with 157 prescriptions and refills. In total Kenneth Rothstein wrote 921 Medicare prescriptions that cost $550K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ursodiol Generic | 157 | 287 | 34 | $25K |
| Mycophenolate Mofetil Generic | 93 | 213 | 20 | $6,939 |
| Prednisone Generic | 53 | 87 | Under 11 | $336 |
| Lactulose Generic | 52 | 77 | 11 | $1,862 |
| Spironolactone Generic | 51 | 78 | 18 | $614 |
| Furosemide Generic | 48 | 74 | 14 | $264 |
| Tacrolimus Generic | 45 | 107 | Under 11 | $6,690 |
| Xifaxan Rifaximin | 39 | 39 | Under 11 | $124K |
| Vemlidy Tenofovir Alafenamide | 34 | 36 | Under 11 | $53K |
| Entecavir Generic | 32 | 54 | Under 11 | $4,846 |
| Pantoprazole Sodium Generic | 29 | 47 | Under 11 | $253 |
| Sirolimus Generic | 28 | 53 | Under 11 | $9,824 |
| Azathioprine Generic | 21 | 44 | Under 11 | $439 |
| Budesonide Dr Budesonide | 19 | 19 | Under 11 | $790 |
| Ocaliva Obeticholic Acid | 15 | 15 | Under 11 | $143K |
Brand drugs: 141 claims; generic drugs: 780 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kenneth Rothstein $6,229 ($6,229 in general payments such as food, travel and fees) from 3 companies. The largest payer was Gilead Sciences, Inc. with $5,699.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.